CAMBRIDGE, Mass. — May 5, 2026 — Leads & Copy — Intellia Therapeutics, Inc. (Nasdaq: NTLA) will participate in fireside chats at several upcoming investor conferences, the company announced today.
Management from the biopharmaceutical company, which focuses on CRISPR gene editing, will be at the Bank of America Securities Health Care Conference on May 12 in Las Vegas (3:40 p.m. PT), the RBC Capital Markets Global Healthcare Conference on May 20 in New York (2:35 p.m. ET), and the Jefferies Global Healthcare Conference on June 3 in New York (4:55 p.m. ET).
The fireside chats will be webcast live on the Events and Presentations page of the Investors & Media section of Intellia’s website. Replays will be available on the same page for approximately 90 days following the events.
Intellia Therapeutics aims to transform the lives of people with severe diseases by developing and commercializing potentially curative treatments. The company focuses on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, and aims to reset the standard for medicine by durably treating the root causes of disease.
Source: Intellia Therapeutics
